Bilateral vestibular schwannomas in older patients: NF2 or chance?

被引:30
作者
Evans, D. G. [1 ]
Freeman, S. [2 ]
Gokhale, C. [1 ]
Wallace, A. [1 ]
Lloyd, S. K. [2 ]
Axon, P. [3 ]
Ward, C. L. [4 ]
Rutherford, S. [4 ]
King, A. [4 ]
Huson, S. M. [1 ]
Ramsden, R. T. [2 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Human Dev, Genom Med,Cent Manchester NHS Fdn Trust,Mancheste, Manchester, Lancs, England
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, Dept Otolaryngol,Inst Human Dev,Manchester Royal, Manchester, Lancs, England
[3] Addenbrookes Hosp Cambridge, Dept Otolaryngol, Cambridge, England
[4] Salford Royal NHS Fdn Trust, Dept Neurosurg, Manchester, Lancs, England
关键词
DIAGNOSTIC-CRITERIA; NEUROFIBROMATOSIS; TYPE-2; RADIATION;
D O I
10.1136/jmedgenet-2014-102973
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Neurofibromatosis type 2 (NF2) is an autosomal dominant condition with high spontaneous mutation rate which predisposes to the development of multiple nerve sheath tumours (schwannomas), meningiomas and ependymoma. The cardinal feature and main diagnostic criterion for the diagnosis of NF2 remains the development of bilateral vestibular schwannoma (BVS). With increasing use of MRI screening the possibility of a 'chance' diagnosis of BVS has been mooted with a potential frequency of one in two million people in their lifetime. Until now, however, no evidence for such an event has been published. We aimed to demonstrate that chance occurrence can occur and to estimate its frequency among those with just BVS late in life. Methods Two vestibular schwannomas from the same patient were DNA sequenced and underwent loss of heterozygosity analysis. Results We show that a man who developed BVS, at ages 52 and 67 years developed these tumours sporadically by demonstrating that there were no molecular events in common between the two tumours. Furthermore from a database of over 1200 patients with NF2, we have estimated that similar to 25% of cases of BVS over 50 years and 50% over 70 years of age where no other features of NF2 are present represent a chance occurrence rather than due to an underlying mosaic or constitutional NF2 mutation. Conclusions Patients presenting with BVS later in life should be appraised of the potential likelihood they may not have NF2 and the resultant further reduction in risks of transmission to offspring.
引用
收藏
页码:422 / 424
页数:3
相关论文
共 15 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management Clinical article [J].
Babu, Ranjith ;
Sharma, Richa ;
Bagley, Jacob H. ;
Hatef, Jeffrey ;
Friedman, Allan H. ;
Adamson, Cory .
JOURNAL OF NEUROSURGERY, 2013, 119 (01) :121-130
[3]  
Baser M. E., 2002, Neurology, V59, P1759
[4]   Empirical development of improved diagnostic criteria for neurofibromatosis 2 [J].
Baser, Michael E. ;
Friedman, Jan M. ;
Joe, Harry ;
Shenton, Andrew ;
Wallace, Andrew J. ;
Ramsden, Richard T. ;
Evans, D. Gareth R. .
GENETICS IN MEDICINE, 2011, 13 (06) :576-581
[5]   Genetic testing and screening of individuals at risk of NF2 [J].
Evans, D. G. ;
Raymond, F. L. ;
Barwell, J. G. ;
Halliday, D. .
CLINICAL GENETICS, 2012, 82 (05) :416-424
[6]   Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service [J].
Evans, D. G. ;
Howard, E. ;
Giblin, C. ;
Clancy, T. ;
Spencer, H. ;
Huson, S. M. ;
Lalloo, F. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (02) :327-332
[7]   Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes [J].
Evans, DGR ;
Birch, JM ;
Ramsden, RT ;
Sharif, S ;
Baser, ME .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (04) :289-294
[8]   Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought [J].
Evans, DGR ;
Moran, T ;
King, A ;
Saeed, S ;
Gurusinghe, J ;
Ramsden, R .
OTOLOGY & NEUROTOLOGY, 2005, 26 (01) :93-97
[9]  
EVANS DGR, 1992, Q J MED, V84, P603
[10]   Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification [J].
Evans, Gareth R. ;
Ramsden, R. T. ;
Shenton, A. ;
Gokhale, C. ;
Bowers, N. L. ;
Huson, S. M. ;
Pichert, G. ;
Wallace, A. .
JOURNAL OF MEDICAL GENETICS, 2007, 44 (07) :424-428